🔗 Share this article

Texas Attorney General Paxton is filing a lawsuit against the producers of Tylenol, claiming the firms hid alleged dangers that the drug created to pediatric brain development.

This legal action comes thirty days after Former President Trump advocated an unproven link between using Tylenol - alternatively called paracetamol - throughout gestation and autism in young ones.

The attorney general is suing the pharmaceutical giant, which formerly manufactured the drug, the only pain reliever approved for pregnant women, and Kenvue, which presently makes it.

In a declaration, he said they "misled consumers by profiting off of pain and promoting medication regardless of the dangers."

The company asserts there is no credible evidence connecting Tylenol to autism.

"These manufacturers lied for decades, deliberately risking millions to boost earnings," the attorney general, from the Republican party, stated.

The company said in a statement that it was "very worried by the perpetuation of misinformation on the reliability of paracetamol and the potential impact that could have on the health of women and children in America."

On its online platform, the company also stated it had "continuously evaluated the pertinent research and there is insufficient valid information that demonstrates a established connection between consuming paracetamol and autism spectrum disorder."

Organizations acting on behalf of doctors and medical practitioners share this view.

The leading OB-GYN organization has said acetaminophen - the primary component in acetaminophen - is one of the few options for women during pregnancy to address discomfort and elevated temperature, which can present major wellness concerns if not addressed.

"In over twenty years of research on the utilization of acetaminophen in pregnancy, not a single reputable study has conclusively proven that the usage of acetaminophen in any stage of gestation results in brain development issues in offspring," the association said.

The lawsuit references latest statements from the previous government in arguing the medication is reportedly hazardous.

In recent weeks, the former president generated worry from medical authorities when he told women during pregnancy to "struggle intensely" not to use acetaminophen when sick.

Federal regulators then issued a notice that doctors should consider limiting the use of acetaminophen, while also declaring that "a proven link" between the medication and autism spectrum disorder in children has not been proven.

The Health Department head Kennedy, who manages the Food and Drug Administration, had vowed in spring to initiate "comprehensive study program" that would determine the source of autism in a limited time.

But authorities advised that finding a sole reason of autism - believed by scientists to be the result of a complex mix of genetic and environmental factors - would be difficult.

Autism is a category of lifelong neurodivergence and disability that influences how persons experience and relate to the surroundings, and is identified using doctors' observations.

In his court filing, the attorney general - who supports Trump who is seeking federal office - asserts Kenvue and Johnson & Johnson "willfully ignored and sought to suppress the science" around acetaminophen and autism.

The case seeks to make the corporations "remove any marketing or advertising" that states acetaminophen is safe for expectant mothers.

The Texas lawsuit mirrors the grievances of a group of guardians of young ones with autism spectrum disorder and ADHD who filed suit against the producers of acetaminophen in recently.

The court dismissed the case, declaring investigations from the plaintiffs' authorities was inconclusive.